Navigation Links
Watson Confirms BYSTOLIC(R) Patent Challenge
Date:3/14/2012

at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release. It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors, risks and uncertainties affecting Watson's business. These factors include, among others, the difficulty of predicting the timing or outcome of product development efforts, including FDA and other regulatory agency approvals and actions, if any; the difficulty of predicting the timing and outcome of the pending patent litigation; the impact of competitive products and pricing; the timing and success of product launches; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson and its third party manufacturers' facilities, products and/or businesses; changes in the laws and regulations, including Medicare and Medicaid, affecting among other things, pricing and reimbursement of pharmaceutical products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's annual report on Form 10-K for the year ended December 31, 2011. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.

BYSTOLIC® is a registered trademark of Forest Laboratories, Inc.  

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)CONTACTS:Investors: 

Patty Eisen
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Watson Launches Generic PROMETRIUM(R)
2. Watson to Present at the Barclays Capital 2012 Global Healthcare Conference
3. Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8%
4. Watson to Present at the 2012 RBC Capital Markets Healthcare Conference
5. Watson to Present at the Citi 2012 Global Healthcare Conference
6. Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion;
7. Watson Provides Update on Generic Lidoderm® Application
8. Watson Reaches Settlement with Mallinckrodt Over Exalgo(R)
9. Watson Confirms Court Stays Preliminary Injunction
10. Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77
11. Watson Acquires Ascent Pharmahealth for AU$375 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , Safinamide significantly improves ... as add-on to levodopa Safinamide is ... in fluctuating PD patients as add-on to levodopa ... ("Newron"), a research and development company focused on ... Zambon S.p.A., a pharmaceutical company strongly committed to ...
(Date:6/18/2013)... 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... the development and commercialization of novel bile acid therapeutics ... of an underwritten public offering of 1,730,000 shares of ... $33.01 per share.  In addition, Intercept has granted the ... additional 259,500 shares of common stock. All ...
(Date:6/18/2013)... 2013 /PRNewswire-iReach/ -- Today E-T-A Circuit Breakers announced ... Module. The X3130, integrated with E-T-A,s double-pole ... appliance inlet module, rocker switch and resettable overcurrent ... allows design engineers to streamline the number of ... by 66 percent - and reduce the overall ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Three-in-One X3130 Appliance Inlet Module 2
(Date:6/19/2013)... 19, 2013 CoachingWebsites, ... coaches, announced today its affiliation with Active ... offer exclusive websites and marketing solutions and capitalize ... new partnership with Active Intelligence shows our overall ... its fullest,” says Greer Van Dyck, Online Marketing ...
(Date:6/19/2013)... NY (PRWEB) June 19, 2013 MinuteHound, ... their cloud-based technology can save businesses up to 8% ... problems which plague traditional time card systems. Their biometric ... small sensing device which clocks them in and out ... prevention of time theft and buddy punching. , ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Over the ... Drug Retailer industry has been growing at an ... in 2013. Many factors have supported the development of ... drugs retailed by drugstores; relatively higher drug prices in ... the government's support for the development of chain drug ...
(Date:6/18/2013)... 19, 2013 "What if adding one ... could boost your health and well-being? Well, there is ... Sublime Beauty®. "It is called Skin Brushing ." ... became a lost art. Now, people are rediscovering this ... Brushing, and so do certain health conscious people. Sublime ...
(Date:6/18/2013)... 2013 Cheap Concert Tickets has released additional ... which gets underway in July. Soccer fans can add ... order. , The popularity and hype of soccer ... fact, the hype of the game triggered the sports-minded citizens ... down the veins of fans from the Caribbean. The ...
Breaking Medicine News(10 mins):Health News:CoachingWebsites (Websites for Coaches) Announces Their Partnership With Active Intelligence, LLC 2Health News:MinuteHound Announces How Cloud Computing Technology Boosts Savings 2Health News:MinuteHound Announces How Cloud Computing Technology Boosts Savings 3Health News:Pharmacies and Drug Retailers in China Industry Research Report – Now Available from IBISWorld 2Health News:Pharmacies and Drug Retailers in China Industry Research Report – Now Available from IBISWorld 3Health News:The Easiest Way to Contribute to Better Health and Well-Being Starting Today and for Under $20, Says Sublime Beauty® 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3
... ... ... Services, LLC ( HCCMIS ), is now utilizing CMN for health-care provider network administration in North ...   Larger worldwide network directory with 400,000+ doctors and 7,000+ facilities ...
... ... USI Affinity, Collegiate Insurance Resources (CIR) warned today that the confusion surrounding ... CIR’s customer service department, many calls are coming in from new college ... plan or believe other aspects of the healthcare reform bill began upon ...
... ... brushes offer single or double-ended brush tips with 50% more cleaning power than the ... Stow, ... to introduce its new Cleanables™ surgical instrument cleaning brushes. Spectrum’s new Cleanables™ medical cleaning ...
... , Exposure to the common virus that causes cold ... the brain and the loss of concentration skills, memory, ... schizophrenia, according to research led by Johns Hopkins scientists. ... impairment usually blamed solely on the disease of schizophrenia ...
... prescribe recommended treatments, study found , FRIDAY, May 28 ... program designed to review current research and guidelines, doctors ... for patients with high blood pressure, a new study ... are reflected in the practices of community physicians remains ...
... (May 28, 2010)Fox Chase Cancer Center investigators find that ... have worse outcomes than patients without circulating tumor cells. Additionally, ... cells are the same, and some may predict worse outcomes ... fellow at Fox Chase, will present the study at the ...
Cached Medicine News:Health News:HCC Medical Insurance Services Chooses CMN as Network Administrator 2Health News:Healthcare Reform Confusion May Create Coverage Gap for College Graduates 2Health News:Healthcare Reform Confusion May Create Coverage Gap for College Graduates 3Health News:Cold sore virus may contribute to cognitive and brain abnormalities in schizophrenia 2Health News:Putting New Medical Guidelines Into Practice Often Difficult 2Health News:Circulating tumor cells correlate with poorer survival in pancreatic cancer patients 2
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
VascoStim 2F are bipolar temporary pacing leads to be used in conjunction with thermodilution catheters with implemented paceport-channel....
The Aescula LV left-heart lead is a stylet-driven, silicone insulated lead with a titanium nitride (TiN) coated platinum-iridium electrode....
Medicine Products: